Cameroon vs China: Protecting minority investors: Ease of shareholder suits index (0-10)
Cameroon
40
in 2013
China
40
in 2013
Cameroon rank
132nd
China rank
132nd
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Cameroon
- China
How they compare
Cameroon currently reports 40 against 40 in China, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Cameroon ahead.
Cameroon ranks 132nd and China ranks 132nd of 191 countries.
Cameroon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40 | 36 | 4 | Cameroon |
| 2010s | 40 | 40 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Cameroon or China?
- Cameroon, at 40 against 40 in China as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Cameroon and China?
- 0, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and China?
- 9 years are reported by both, from 2005 to 2013.
- How do Cameroon and China rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Cameroon ranks 132nd and China ranks 132nd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.